TheraRadar
← Back
Data updated: Jun 28, 2026

SUNOVION PHARMS INC

Specialty
Pharmaceuticals

SUNOVION PHARMS INC is a specialty pharmaceutical company with 1 FDA-approved products.

2010
Since
1
Drugs
-
Trials
0
New Drugs (2yr)
Modality:
1 Small Molecules

SUNOVION PHARMS INC's Key Drugs

SUNOVION PHARMS INC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).

No active drugs

SUNOVION PHARMS INC's Recent FDA Approvals

New NDA/BLA approvals for SUNOVION PHARMS INC over the last two years — novel drugs only, excluding generics and label supplements.

No recent approvals

SUNOVION PHARMS INC's Therapeutic Areas

Disease areas where SUNOVION PHARMS INC has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.

No indication data

SUNOVION PHARMS INC Pipeline Snapshot

Active clinical trials for SUNOVION PHARMS INC across all therapeutic areas, from ClinicalTrials.gov.

No active pipeline data available

Pro Intelligence Preview

Deep insights for investors and analysts

Revenue Insights

  • • Top drug revenue breakdown
  • • Drug-level revenue analysis

Trial Catalysts

  • • Active trial monitoring
  • • Phase 3 readout tracking

Patent Risk

  • • Patent expiration timeline
  • • Revenue at risk analysis

Compare Companies

  • • Side-by-side pipeline analysis
  • • Revenue & market share comparison
Unlock Full Intelligence

Revenue forecasts • Trial milestones • Patent risk modeling